▶ 調査レポート

急性呼吸窮迫症候群(ARDS)治療薬のグローバル市場調査 2019年
• 英文タイトル：Global Acute Respiratory Distress Syndrome Therapeutics Market Professional Survey Report 2019

QYResearchが調査・発行した産業分析レポートです。急性呼吸窮迫症候群(ARDS)治療薬のグローバル市場調査 2019年 / Global Acute Respiratory Distress Syndrome Therapeutics Market Professional Survey Report 2019 / QYR9NV00152資料のイメージです。• レポートコード：QYR9NV00152
• 出版社/出版日：QYResearch / 2019年11月12日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、102ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・ヘルスケア
• 販売価格（消費税別）
  Single User￥525,000 (USD3,500)▷ お問い合わせ
  Enterprise License￥1,050,000 (USD7,000)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
※本調査レポートは、急性呼吸窮迫症候群(ARDS)治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、メチルプレドニゾロン、ヒドロコルチゾン、注射用子牛肺サーファクタント、その他に、用途別には、入院患者、外来患者にセグメント区分し、急性呼吸窮迫症候群(ARDS)治療薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・急性呼吸窮迫症候群(ARDS)治療薬の世界市場概要
・急性呼吸窮迫症候群(ARDS)治療薬の製造コスト構成分析
・急性呼吸窮迫症候群(ARDS)治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・急性呼吸窮迫症候群(ARDS)治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・急性呼吸窮迫症候群(ARDS)治療薬のセグメント分析（種類別）
（メチルプレドニゾロン、ヒドロコルチゾン、注射用子牛肺サーファクタント、その他）
・急性呼吸窮迫症候群(ARDS)治療薬のセグメント分析（用途別）
（入院患者、外来患者）
・急性呼吸窮迫症候群(ARDS)治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Therabron Therapeutics, Inc.、Serendex Pharmaceuticals A/S、Silence Therapeutics Plc、Histocell S.L.、Altor BioScience Corporation、Athersys, Inc.、Faron Pharmaceuticals Oy、FirstString Research, Inc.、GlaxoSmithKline Plc、Phylogica Limited、）
・急性呼吸窮迫症候群(ARDS)治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

The global Acute Respiratory Distress Syndrome Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Acute Respiratory Distress Syndrome Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Respiratory Distress Syndrome Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Acute Respiratory Distress Syndrome Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Acute Respiratory Distress Syndrome Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Therabron Therapeutics, Inc.
Serendex Pharmaceuticals A/S
Silence Therapeutics Plc
Histocell S.L.
Altor BioScience Corporation
Athersys, Inc.
Faron Pharmaceuticals Oy
FirstString Research, Inc.
GlaxoSmithKline Plc
Phylogica Limited

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Methylprednisolone
Hydrocortisone
Calf Pulmonary Surfactant for Injection
Others

Segment by Application
In-Patient
Out-Patient

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Acute Respiratory Distress Syndrome Therapeutics
1.1 Definition of Acute Respiratory Distress Syndrome Therapeutics
1.2 Acute Respiratory Distress Syndrome Therapeutics Segment by Type
1.2.1 Global Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Methylprednisolone
1.2.3 Hydrocortisone
1.2.4 Calf Pulmonary Surfactant for Injection
1.2.5 Others
1.3 Acute Respiratory Distress Syndrome Therapeutics Segment by Applications
1.3.1 Global Acute Respiratory Distress Syndrome Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 In-Patient
1.3.3 Out-Patient
1.4 Global Acute Respiratory Distress Syndrome Therapeutics Overall Market
1.4.1 Global Acute Respiratory Distress Syndrome Therapeutics Revenue (2014-2025)
1.4.2 Global Acute Respiratory Distress Syndrome Therapeutics Production (2014-2025)
1.4.3 North America Acute Respiratory Distress Syndrome Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Acute Respiratory Distress Syndrome Therapeutics Status and Prospect (2014-2025)
1.4.5 China Acute Respiratory Distress Syndrome Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Acute Respiratory Distress Syndrome Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Status and Prospect (2014-2025)
1.4.8 India Acute Respiratory Distress Syndrome Therapeutics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Acute Respiratory Distress Syndrome Therapeutics
2.3 Manufacturing Process Analysis of Acute Respiratory Distress Syndrome Therapeutics
2.4 Industry Chain Structure of Acute Respiratory Distress Syndrome Therapeutics

3 Development and Manufacturing Plants Analysis of Acute Respiratory Distress Syndrome Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Acute Respiratory Distress Syndrome Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Acute Respiratory Distress Syndrome Therapeutics
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Acute Respiratory Distress Syndrome Therapeutics Production and Capacity Analysis
4.2 Acute Respiratory Distress Syndrome Therapeutics Revenue Analysis
4.3 Acute Respiratory Distress Syndrome Therapeutics Price Analysis
4.4 Market Concentration Degree

5 Acute Respiratory Distress Syndrome Therapeutics Regional Market Analysis
5.1 Acute Respiratory Distress Syndrome Therapeutics Production by Regions
5.1.1 Global Acute Respiratory Distress Syndrome Therapeutics Production by Regions
5.1.2 Global Acute Respiratory Distress Syndrome Therapeutics Revenue by Regions
5.2 Acute Respiratory Distress Syndrome Therapeutics Consumption by Regions
5.3 North America Acute Respiratory Distress Syndrome Therapeutics Market Analysis
5.3.1 North America Acute Respiratory Distress Syndrome Therapeutics Production
5.3.2 North America Acute Respiratory Distress Syndrome Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Acute Respiratory Distress Syndrome Therapeutics Import and Export
5.4 Europe Acute Respiratory Distress Syndrome Therapeutics Market Analysis
5.4.1 Europe Acute Respiratory Distress Syndrome Therapeutics Production
5.4.2 Europe Acute Respiratory Distress Syndrome Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Acute Respiratory Distress Syndrome Therapeutics Import and Export
5.5 China Acute Respiratory Distress Syndrome Therapeutics Market Analysis
5.5.1 China Acute Respiratory Distress Syndrome Therapeutics Production
5.5.2 China Acute Respiratory Distress Syndrome Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Acute Respiratory Distress Syndrome Therapeutics Import and Export
5.6 Japan Acute Respiratory Distress Syndrome Therapeutics Market Analysis
5.6.1 Japan Acute Respiratory Distress Syndrome Therapeutics Production
5.6.2 Japan Acute Respiratory Distress Syndrome Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Acute Respiratory Distress Syndrome Therapeutics Import and Export
5.7 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Market Analysis
5.7.1 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Production
5.7.2 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Import and Export
5.8 India Acute Respiratory Distress Syndrome Therapeutics Market Analysis
5.8.1 India Acute Respiratory Distress Syndrome Therapeutics Production
5.8.2 India Acute Respiratory Distress Syndrome Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Acute Respiratory Distress Syndrome Therapeutics Import and Export

6 Acute Respiratory Distress Syndrome Therapeutics Segment Market Analysis (by Type)
6.1 Global Acute Respiratory Distress Syndrome Therapeutics Production by Type
6.2 Global Acute Respiratory Distress Syndrome Therapeutics Revenue by Type
6.3 Acute Respiratory Distress Syndrome Therapeutics Price by Type

7 Acute Respiratory Distress Syndrome Therapeutics Segment Market Analysis (by Application)
7.1 Global Acute Respiratory Distress Syndrome Therapeutics Consumption by Application
7.2 Global Acute Respiratory Distress Syndrome Therapeutics Consumption Market Share by Application (2014-2019)

8 Acute Respiratory Distress Syndrome Therapeutics Major Manufacturers Analysis
8.1 Therabron Therapeutics, Inc.
8.1.1 Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.1.2 Therabron Therapeutics, Inc. Product Introduction, Application and Specification
8.1.3 Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Serendex Pharmaceuticals A/S
8.2.1 Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.2.2 Serendex Pharmaceuticals A/S Product Introduction, Application and Specification
8.2.3 Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Silence Therapeutics Plc
8.3.1 Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.3.2 Silence Therapeutics Plc Product Introduction, Application and Specification
8.3.3 Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Histocell S.L.
8.4.1 Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.4.2 Histocell S.L. Product Introduction, Application and Specification
8.4.3 Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Altor BioScience Corporation
8.5.1 Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.5.2 Altor BioScience Corporation Product Introduction, Application and Specification
8.5.3 Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Athersys, Inc.
8.6.1 Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.6.2 Athersys, Inc. Product Introduction, Application and Specification
8.6.3 Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Faron Pharmaceuticals Oy
8.7.1 Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.7.2 Faron Pharmaceuticals Oy Product Introduction, Application and Specification
8.7.3 Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 FirstString Research, Inc.
8.8.1 FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.8.2 FirstString Research, Inc. Product Introduction, Application and Specification
8.8.3 FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 GlaxoSmithKline Plc
8.9.1 GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.9.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
8.9.3 GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Phylogica Limited
8.10.1 Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.10.2 Phylogica Limited Product Introduction, Application and Specification
8.10.3 Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Acute Respiratory Distress Syndrome Therapeutics Market
9.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Trend Analysis
9.1.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Acute Respiratory Distress Syndrome Therapeutics Regional Market Trend
9.2.1 North America Acute Respiratory Distress Syndrome Therapeutics Forecast 2019-2025
9.2.2 Europe Acute Respiratory Distress Syndrome Therapeutics Forecast 2019-2025
9.2.3 China Acute Respiratory Distress Syndrome Therapeutics Forecast 2019-2025
9.2.4 Japan Acute Respiratory Distress Syndrome Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Forecast 2019-2025
9.2.6 India Acute Respiratory Distress Syndrome Therapeutics Forecast 2019-2025
9.3 Acute Respiratory Distress Syndrome Therapeutics Market Trend (Product Type)
9.4 Acute Respiratory Distress Syndrome Therapeutics Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Acute Respiratory Distress Syndrome Therapeutics Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Acute Respiratory Distress Syndrome Therapeutics
Table Global Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Acute Respiratory Distress Syndrome Therapeutics Production Market Share by Types in 2018
Figure Methylprednisolone Product Picture
Figure Hydrocortisone Product Picture
Figure Calf Pulmonary Surfactant for Injection Product Picture
Figure Others Product Picture
Table Global Acute Respiratory Distress Syndrome Therapeutics Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Acute Respiratory Distress Syndrome Therapeutics Consumption Market Share by Applications in 2018
Figure In-Patient
Figure Out-Patient
Figure Global Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD) (2014-2025)
Figure Global Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs) (2014-2025)
Figure North America Acute Respiratory Distress Syndrome Therapeutics Market Size (Million USD) (2014-2025)
Figure Europe Acute Respiratory Distress Syndrome Therapeutics Market Size (Million USD) (2014-2025)
Figure China Acute Respiratory Distress Syndrome Therapeutics Market Size (Million USD) (2014-2025)
Figure Japan Acute Respiratory Distress Syndrome Therapeutics Market Size (Million USD) (2014-2025)
Figure Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Market Size (Million USD) (2014-2025)
Figure India Acute Respiratory Distress Syndrome Therapeutics Market Size (Million USD) (2014-2025)
Table Acute Respiratory Distress Syndrome Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Acute Respiratory Distress Syndrome Therapeutics in 2018
Figure Manufacturing Process Analysis of Acute Respiratory Distress Syndrome Therapeutics
Figure Industry Chain Structure of Acute Respiratory Distress Syndrome Therapeutics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Acute Respiratory Distress Syndrome Therapeutics Manufacturing Plants Distribution
Table Acute Respiratory Distress Syndrome Therapeutics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Acute Respiratory Distress Syndrome Therapeutics Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs) of Major Manufacturers (2014-2019)
Table Acute Respiratory Distress Syndrome Therapeutics Production Market Share of Major Manufacturers (2014-2019)
Figure Acute Respiratory Distress Syndrome Therapeutics Production Share by Manufacturers in 2018
Table Acute Respiratory Distress Syndrome Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share of Major Manufacturers (2014-2019)
Figure Acute Respiratory Distress Syndrome Therapeutics Revenue Share by Manufacturers in 2018
Table Acute Respiratory Distress Syndrome Therapeutics Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Acute Respiratory Distress Syndrome Therapeutics Production by Regions 2014-2019 (K Pcs)
Table Global Acute Respiratory Distress Syndrome Therapeutics Production Market Share by Regions 2014-2019
Figure Global Acute Respiratory Distress Syndrome Therapeutics Production Market Share by Regions in 2018
Table Global Acute Respiratory Distress Syndrome Therapeutics Revenue by Regions 2014-2019 (Million USD)
Table Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Regions in 2018
Table Global Acute Respiratory Distress Syndrome Therapeutics Consumption by Regions 2014-2019 (K Pcs)
Table Global Acute Respiratory Distress Syndrome Therapeutics Consumption Market Share by Regions 2014-2019
Figure North America Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure North America Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table North America Acute Respiratory Distress Syndrome Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Europe Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Acute Respiratory Distress Syndrome Therapeutics Production, Consumption Import and Export (K Pcs)
Figure China Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure China Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table China Acute Respiratory Distress Syndrome Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Japan Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Acute Respiratory Distress Syndrome Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Production, Consumption Import and Export (K Pcs)
Figure India Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure India Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table India Acute Respiratory Distress Syndrome Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Acute Respiratory Distress Syndrome Therapeutics Market Share by Application (2014-2019)
Figure Global Value (Consumption) Acute Respiratory Distress Syndrome Therapeutics Market Share by Application (2014-2019)
Table Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Figure Global Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Acute Respiratory Distress Syndrome Therapeutics Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Acute Respiratory Distress Syndrome Therapeutics by Type (2019-2025)
Table Global Consumption (K Pcs) of Acute Respiratory Distress Syndrome Therapeutics by Application (2019-2025)
Table Acute Respiratory Distress Syndrome Therapeutics Distributors List
Table Acute Respiratory Distress Syndrome Therapeutics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 骨髄異形成症候群（MDS）治療薬のグローバル市場調査 2019年
    Global Myelodysplastic Syndrome (MDS) Therapeutics Market Professional Survey Report 2019
    QYR9NV08733 2019年11月14日 107Pages
    ※本調査レポートは、骨髄異形成症候群（MDS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アザシチジン、レナリドマイド、デシタビン、デフェラシロクス...
  • 急性心不全(AHF)治療薬のグローバル市場調査 2019年
    Global Acute Heart Failure (AHF) Therapeutics Market Professional Survey Report 2019
    QYR9NV00150 2019年11月12日 108Pages
    ※本調査レポートは、急性心不全(AHF)治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、β遮断薬、カルシウム拮抗薬、強心配糖体、利尿薬、モルヒネ、血管拡...
  • 呼吸器合胞体ウイルス（RSV）治療薬のグローバル市場調査 2019年
    Global Respiratory Syncytial Virus (RSV) Therapeutics Market Professional Survey Report 2019
    QYR9NV11228 2019年11月14日 104Pages
    ※本調査レポートは、呼吸器合胞体ウイルス（RSV）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、パリビズマブ、リバビリン、その他に、用途別には、病院薬...
  • 呼吸器合胞体ウイルス（RSV）治療薬のグローバル市場調査 2019年
    Global Respiratory Syncytial Virus (RSV) Therapeutics Market Professional Survey Report 2019
    QYR9NV11228 2019年11月14日 104Pages
    ※本調査レポートは、呼吸器合胞体ウイルス（RSV）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、パリビズマブ、リバビリン、その他に、用途別には、病院薬...
  • 多嚢胞性卵巣症候群（PCOS）治療薬のグローバル市場調査 2019年
    Global Polycystic Ovary Syndrome (PCOS) Drugs Market Professional Survey Report 2019
    QYR9NV10204 2019年11月14日 105Pages
    ※本調査レポートは、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧...
  • 多嚢胞性卵巣症候群（PCOS）治療薬のグローバル市場調査 2019年
    Global Polycystic Ovary Syndrome (PCOS) Drugs Market Professional Survey Report 2019
    QYR9NV10204 2019年11月14日 105Pages
    ※本調査レポートは、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧...
  • 多嚢胞性卵巣症候群（PCOS）治療法のグローバル市場：規模・現状・予測2019-2025
    Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9NV18299 2019年11月18日 92Pages
    ※当調査レポートでは、多嚢胞性卵巣症候群（PCOS）治療法の世界市場について調査・分析し、多嚢胞性卵巣症候群（PCOS）治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口避妊薬、排卵誘発剤、...
  • レット症候群治療薬のグローバル市場調査 2019年
    Global Rett Syndrome Therapeutics Market Professional Survey Report 2019
    QYR9NV11253 2019年11月14日 115Pages
    ※本調査レポートは、レット症候群治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BHV-5000、ブリオスタチン-1、CPT-157633、ELX-02...
  • レット症候群治療薬のグローバル市場調査 2019年
    Global Rett Syndrome Therapeutics Market Professional Survey Report 2019
    QYR9NV11253 2019年11月14日 115Pages
    ※本調査レポートは、レット症候群治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BHV-5000、ブリオスタチン-1、CPT-157633、ELX-02...